CCL2 and neoplasm: For instance, the inhibition of LOX can reduce the production of CCL2 and IL-10 by tumor-associated macrophages in RCC, leading to the suppression of immune escape and cancer-related inflammation via LOX-dependent arachidonic acid metabolism33.